Bayer, Meiogenix Collaborate to Accelerate Agricultural Innovation Through the Development of Unique Technologies
10 Febbraio 2020 - 7:00AM
JCN Newswire (English)
Monheim, Germany and Paris, France, Feb 10, 2020 - (ACN
Newswire) - Bayer and Meiogenix, a biotech company focused on
next-generation breeding technologies, announced today a
collaboration to advance agricultural research and development by
accelerating the development of Meiogenix's proprietary
technologies related to plant breeding and genome editing
applications. This new research collaboration has the potential to
deliver much-needed plant health and nutrition improvements to food
crops so farmers can more efficiently and sustainably grow improved
plant varieties that deliver the types of foods consumers want.
|
Figure 1: Plants Genetic
Diversity - To view an enhanced version of Figure 1, please visit:
https://orders.newsfilecorp.com/files/6942/52265_3248f08fd41dbbdb_001full.jpg |
"Farmers need innovative solutions as they face limited natural
resources and a changing climate," said Jeremy Williams, Head of
Plant Biotechnology, Crop Science Research & Development
(R&D) at Bayer. "Access to Meiogenix's proprietary technologies
could improve the precision and speed with which our breeders
enhance crops, which could ultimately accelerate those solutions
for the diverse needs of people and our planet."
Meiogenix's proprietary technologies are used to induce the
exchange of genomic regions between chromosomes of plant cells
during meiosis, the natural process that generates genetic
diversity during plant breeding. Technologies based on meiotic
recombination provide commercial crops with access to a broader
genetic diversity, including complex traits for improved food
quality, plants' resistance to diseases and pests, and higher yield
potential. The resulting hybrids and varieties have the potential
to deliver value throughout the food chain, from farmers to
consumers.
"Over the past decade, we have assembled unique know-how,
intellectual property portfolio and network of experts to help
generate biodiversity and accelerate breeding through modulating
meiotic recombination. We are proud to collaborate with Bayer to
develop the next generations of crops," said Giacomo Bastianelli,
Co-founder & CEO of Meiogenix.
"Agriculture is facing the challenge of adjusting plant physiology
to rapid climate, pest and disease changes, as well as preparing
the next generation of healthier food. Collaborating on these new
breeding technologies will be key to bringing innovative solutions
to farmers and consumers," said Luc Mathis, strategic advisor of
Meiogenix.
As part of the project, Meiogenix will collaborate with top
academic institutes to advance these technologies in crops.
Bayer offers a wide range of educational materials regarding plant
breeding and gene editing technologies on its website.
Find more information at www.bayer.com and at www.meiogenix.com
Press Contact
Bayer: Holger Elfes, +49 2173 38-3270, holger.elfes@bayer.com
Meiogenix: Caroline Carmagnol, +33 6 64 18 99 59,
caroline@alizerp.com
Forward-Looking Statements
This release may contain forward-looking statements based on
current assumptions and forecasts made by Bayer management. Various
known and unknown risks, uncertainties, and other factors could
lead to material differences between the actual future results,
financial situation, development or performance of the company and
the estimates given here. These factors include those discussed in
Bayer's public reports which are available on the Bayer website at
www.bayer.com. The company assumes no liability whatsoever to
update these forward-looking statements or to conform them to
future events or developments.
Related Links
Meiogenix Technologies
https://www.newsfilecorp.com/redirect/bL0xiyao
Breeding and gene editing at Bayer
https://www.newsfilecorp.com/redirect/3ALgsvEX
To view the source version of this press release, please visit
https://www.newsfilecorp.com/release/52265
Source: Meiogenix
Copyright 2020 ACN Newswire . All rights reserved. |
Grafico Azioni Bayer (TG:BAYN)
Storico
Da Mar 2024 a Apr 2024
Grafico Azioni Bayer (TG:BAYN)
Storico
Da Apr 2023 a Apr 2024